NYSE$DVA

DaVita HealthCare Partners Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

DaVita reported a positive quarter, enhancing clinical capabilities and optimizing revenue operations and cost structure.

DaVita Inc. announced financial results for Q2 2024, with consolidated revenues of $3.187 billion and operating income of $506 million. Diluted earnings per share were $2.50, and adjusted diluted earnings per share were $2.59. The company repurchased 2.7 million shares of its common stock at an average price of $140.14 per share.

  • Consolidated revenues reached $3.187 billion.
  • Operating income totaled $506 million.
  • Diluted earnings per share (EPS) stood at $2.50, with adjusted diluted EPS at $2.59.
  • Operating cash flow was $799 million, and free cash flow was $654 million.

Headline financials

Total Revenue

$3.19B

Previous: $3B+6.2%
EPS

$2.50

Previous: $2.08+20.2%
U.S. Dialysis Treatments

7.4M

Previous: 7.2M+2.9%
U.S. Dialysis Avg Treatments per Day

95.5K

Previous: 92.7K+3.0%
Capital Expenditures

-$246M

Previous: -$272M+9.7%
Free Cash Flow

-$23.1M

Previous: -$93.5M+75.3%
Net Income

$223M

Previous: $179M+24.6%
Operating Income

$506M

Previous: $405M+24.9%
Gross Profit

$3.19B

Previous: $3B+6.2%
Cash & Equivalents

$416M

Previous: $327M+27.2%
Total Assets

$17B

Previous: $17B+0.4%
Stock-Based Comp

$24.3M

Previous: $29.8M-18.6%

Revenue & EPS history

DaVita · Revenue · Quarterly

$3.19B

Q2 2024+6.2%vs Q2 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

DaVita · $3.14B total across 3 segments · Q3 2023

  • U.S. Dialysis Patient Services
    $2.79B+3.0%
  • International Dialysis Patient Service
    $200M+14.3%
  • Integrated Kidney Care
    $158M+81.6%

Forward guidance

DaVita provided adjusted operating income guidance between $1.910 billion and $2.010 billion, adjusted diluted net income per share attributable to DaVita Inc. between $9.25 and $10.05, and free cash flow between $950 million and $1.200 billion.

Tailwinds

  • Adjusted operating income is expected to be between $1.910 billion and $2.010 billion.
  • Adjusted diluted net income per share attributable to DaVita Inc. is projected to be between $9.25 and $10.05.
  • Free cash flow is anticipated to range from $950 million to $1.200 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+1.6%

Avg return

30 days after

54%

39 / 72 earnings

Positive

+14.7%

Q3 2019

Best reaction

-24.5%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%+22.2%+22.4%
Q4 2025+11.0%+26.7%+34.9%
Q3 2025-6.0%-5.2%-5.4%
Q1 2025-0.2%+0.7%-4.9%
Q4 2024-11.1%-12.5%-19.0%
Q3 2024-10.1%-9.8%+5.5%
Q2 2024-1.1%+3.6%+9.8%
Q1 2024-3.8%-1.5%+5.3%
Q4 2023+8.0%+6.9%+19.0%
Q3 2023+7.4%+5.1%+33.9%
Q2 2023+6.7%+8.6%+1.0%
Q1 2023+13.8%+5.9%+13.7%
Q4 2022-0.3%-0.3%-8.4%
Q3 2022-24.5%-27.9%-23.6%
Q2 2022+2.7%+1.8%+1.3%
Q1 2022-7.1%-5.0%-12.7%
Q4 2021-1.2%+3.5%-2.6%
Q3 2021-6.9%-6.2%-12.3%
Q2 2021+10.2%+9.7%+10.0%
Q1 2021+2.8%+8.9%+6.0%
Q4 2020-7.4%-8.1%-4.4%
Q3 2020-0.0%+7.7%+27.4%
Q2 2020-4.3%-8.5%-4.8%
Q1 2020+9.6%+7.5%+9.7%
Q4 2019+8.8%+5.7%-8.0%
Q3 2019+14.7%+13.6%+17.9%
Q2 2019+0.4%-1.5%-5.8%
Q1 2019-10.4%-9.8%-19.4%
Q4 2018+1.3%+3.0%-6.7%
Q3 2018+1.3%-1.5%-14.9%
Q2 2018+5.4%+3.9%-1.4%
Q1 2018+4.7%+1.2%+5.9%
Q4 2017+1.8%+0.3%-5.4%
Q3 2017-8.5%-7.4%+13.0%
Q2 2017-9.8%-10.9%-9.6%
Q1 2017-3.8%-5.3%-2.4%
Q4 2016+3.2%+6.2%+4.5%
Q3 2016+1.1%+0.1%+11.1%
Q2 2016-6.0%-10.1%-16.4%
Q1 2016+2.9%
Q4 2015-1.7%
Q3 2015-0.9%
Q2 2015+1.0%
Q1 2015-1.1%
Q4 2014-3.8%
Q3 2014-3.9%
Q2 2014+0.1%
Q1 2014-2.8%
Q4 2013+3.9%
Q3 2013-3.0%
Q2 2013-2.9%
Q1 2013+9.4%
Q4 2012-1.1%
Q3 2012+1.4%
Q2 2012-1.1%
Q1 2012-4.9%
Q4 2011+0.3%
Q3 2011+0.8%
Q2 2011-0.2%
Q1 2011+2.9%
Q4 2010+2.4%
Q3 2010-0.4%
Q2 2010+3.3%
Q1 2009+1.1%
Q1 2010+0.3%
Q4 2009-0.1%
Q3 2009+0.1%
Q3 2008+0.1%
Q2 2008+4.6%
Q4 2008+4.6%
Q2 2009+4.6%
Q4 2007+4.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro